Dido disruption leads to centrosome amplification and mitotic checkpoint defects compromising chromosome stability

Proceedings of the National Academy of Sciences of the United States of America

Volumn 104, Issue 8, 2007, Pages 2691-2696

  Trachana, Varvara ^a   Van Wely, Karel H M ^a   Guerrero, Astrid Alonso ^a   Fütterer, Agnes ^a   Martinez A, Carlos ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

Aneuploidy; Cell cycle; Genomic stability

Indexed keywords

CELL PROTEIN; CENTROSOME ASSOCIATED PROTEIN; DIDO3 PROTEIN; GAMMA TUBULIN; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; HYDROXYUREA; NOCODAZOLE; PACLITAXEL; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANEUPLOIDY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CYCLE; CENTROSOME; CHROMOSOMAL INSTABILITY; CYTOGENETICS; DIDO GENE; EMBRYO; FIBROBLAST; GENE; GENE MUTATION; GENE TARGETING; HEMATOLOGIC MALIGNANCY; IMMUNOFLUORESCENCE MICROSCOPY; MITOSIS; MOUSE; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; NONHUMAN; PRIORITY JOURNAL; WESTERN BLOTTING;

ANIMALS; CENTROSOME; CHROMOSOMAL INSTABILITY; CYTOKINESIS; DNA-BINDING PROTEINS; FIBROBLASTS; GENE TARGETING; HELA CELLS; HUMANS; MICE; MITOSIS; MITOTIC SPINDLE APPARATUS; MUTATION; PROTEIN TRANSPORT; TRANSCRIPTION FACTORS; TUBULIN;

MUS;

EID: 33847324862     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0611132104     Document Type: Article

References (43)

1. Doxsey S, McCollum D, Theurkauf W (2005) Annu Rev Cell Dev Biol 21:411-434.
2. Moritz M, Braunfeld MB, Sedat JW, Alberts B, Agard DA (1995) Nature 378:638-640.
3. Rudner AD, Murray AW (1996) Curr Opin Cell Biol 8:773-780.
4. Doxsey SJ (2001) Nat Cell Biol 3:105-108.
5. Musacchio A, Hardwick KG (2002) Nat Rev Mol Cell Biol 3:731-741.
6. Millband DN, Hardwick KG (2002) Mol Cell Biol 22:2728-2742.
7. Taylor SS, Scott MI, Holland AJ (2004) Chromosome Res 12:599-616.
8. Yu H (2002) Curr Opin Cell Biol 14:706-714.
9. Kops GJ, Weaver BA, Cleveland DW (2005) Nat Rev Cancer 5:773-785.
10. Cahill DP, Lengauer C, Yu J, Riggins GJ, Willson JK, Markowitz SD, Kinzler KW, Vogelstein B (1998) Nature 392:300-303.
11. Shichiri M, Yoshinaga K, Hisatomi H, Sugihara K, Hirata Y (2002) Cancer Res 62:13-17.
12. Shin HJ, Baek KH, Jeon AH, Park MT, Lee SJ, Kang CM, Lee HS, Yoo SH, Chung DH, Sung YC, et al. (2003) Cancer Cell 4:483-497.
13. Kops GJ, Foltz DR, Cleveland DW (2004) Proc Natl Acad Sci USA 101:8699-8704.
14. Weaver BA, Cleveland DW (2005) Cancer Cell 8:7-12.
15. Michel LS, Liberal V, Chatterjee A, Kirchwegger R, Pasche B, Gerald W, Dobles M, Sorger PK, Murty VV, Benezra R (2001) Nature 409:355-359.
16. Baker DJ, Jeganathan KB, Cameron JD, Thompson M, Juneja S, Kopecka A, Kumar R, Jenkins RB, de Groen PC, Roche P, et al. (2004) Nat Genet 36:744-749.
17. Meraldi P, Honda R, Nigg EA (2004) Curr Opin Genet Dev 14:29-36.
18. Lengauer C, Kinzler KW, Vogelstein B (1998) Nature 396:643-649.
19. Mitrou PS, Fischer M, Hubner K (1975) Acta Haematol 54:271-279.
20. Grisendi S, Bernardi R, Rossi M, Cheng K, Khandker L, Manova K, Pandolfi PP (2005) Nature 437:147-153.
21. Fütterer A, Campanero MR, Leonardo E, Criado LM, Flores JM, Hernandez JM, San Miguel JF, Martínez-A C (2005) J Clin Invest 115:2351-2362.
22. Rojas AM, Sanchez-Pulido L, Fütterer A, van Wely KH, Martínez-A C, Valencia A (2005) FEBS J 272:3505-3511.
23. Palazzo RE, Vogel JM, Schnackenberg BJ, Hull DR, Wu X (2000) Curr Top Dev Biol 49:449-470.
24. Salisbury JL (1995) Curr Opin Cell Biol 7:39-45.
25. Lentini L, lovino F, Amato A, Di Leonardo A (2005) Cancer Lett 238:153-160.
26. Wahl AF, Donaldson KL, Fairchild C, Lee FY, Foster SA, Demers GW, Galloway DA (1996) Nat Med 2:72-79.
27. Andersen JS, Wilkinson CJ, Mayor T, Mortensen P, Nigg EA, Mann M (2003) Nature 426:570-574.
28. Neben K, Giesecke C, Schweizer S, Ho AD, Kramer A (2003) Blood 101:289-291.
29. Kearns WG, Yamaguchi H, Young NS, Liu JM (2004) Genes Chromosomes Cancer 40:329-333.
30. Giehl M, Fabarius A, Frank O, Hochhaus A, Hafner M, Hehlmann R, Seifarth W (2005) Leukemia 19:1192-1197.
31. Hoyt MA, Totis L, Roberts BT (1991) Cell 66:507-517.
32. Rieder CL, Maiato H (2004) Dev Cell 7:637-651.
33. Li JJ, Li SA (2006) Pharmacol Ther 11:974-984.
34. Dai W, Wang Q, Liu T, Swamy M, Fang Y, Xie S, Mahmood R, Yang YM, Xu M, Rao CV (2004) Cancer Res 64:440-445.
35. Takahashi T, Haruki N, Nomoto S, Masuda A, Saji S, Osada H (1999) Oncogene 18:4295-4300.
36. Hollander MC, Sheikh MS, Bulavin DV, Lundgren K, Augeri-Henmueller L, Shehee R, Molinaro TA, Kim KE, Tolosa E, Ashwell JD, et al (1999) Nat Genet 23:176-184.
37. Hollander MC, Philburn RT, Patterson AD, Wyatt MA, Fornace AJ, Jr (2005) Cell Cycle 4:704-709.
38. Nigg EA (2002) Nat Rev Cancer 2:815-825.
39. Hinchcliffe EH, Miller FJ, Cham M, Khodjakov A, Sluder G (2001) Science 291:1547-1550.
40. Kramer A, Mailand N, Lukas C, Syljuasen RG, Wilkinson CJ, Nigg EA, Bartek J, Lukas J (2004) Nat Cell Biol 6:884-891.
41. Huang J, Raff JW (1999) EMBO J 18:2184-2195.
42. Piel M, Nordberg J, Euteneuer U, Bornens M (2001) Science 291:1550-1553.
43. Garcia-Domingo D, Leonardo E, Grandien A, Martinez P, Albar JP, Izpisua-Belmonte JC, Martinez-A C (1999) Proc Natl Acad Sci USA 96:7992-7997.